Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-036055

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Behbahani Ali Director 2022-06-09 Grant or award · Stock Option (Right to Buy) +12,000 12,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…